Add BrightSurf on Google Email

SUNY College of Optometry foundation features AI and myopia leaders at inaugural Advancing Vision Summit on September 25

The summit explores the intersection of AI, eye care, and public health, with a focus on artificial intelligence, oculomics, population health, and myopia management. The event brings together leaders from healthcare, technology, and optometry to discuss innovative approaches to improve eye health and expand access to care.

Cataract surgery continues to improve across Europe

The latest figures from the European Registry of Quality Outcomes for Cataract and Refractive Surgery show significant improvements in safety and efficacy, with complications such as posterior capsule rupture occurring at a low rate. The registry has recorded nearly five million cataract surgeries, with the most common procedure being ...

SourceEuropean Society of Cataract and Refractive Surgeons·TypeData/statistical analysis·DateSep 14, 2026

High myopia control is not only about axial length: study suggests posterior scleral reinforcement may slow early fundus changes in children

A three-year study found that posterior scleral reinforcement slowed macular fundus tessellation and preserved subfoveal choroidal thickness in children with progressive high myopia. The researchers suggest that PSR may help delay early myopic maculopathy-related changes, possibly through mechanisms beyond axial elongation.

SourceEye Discovery·JournalEye Discovery·TypeObservational study·DateAug 10, 2026

How can patients with irregular corneas see more clearly? Multicenter study shows short-term vision improvement with a four-zone scleral lens

A multicenter study found that patients with irregular corneas achieved significant visual acuity improvements after wearing a four-zone scleral lens for three months. The lenses showed encouraging fitting efficiency and patient comfort, with minimal adverse events reported.

SourceEye Discovery·JournalEye Discovery·TypeObservational study·DateJul 13, 2026

Seeing clearly is not the whole story: A VISUMAX 800 KLEx study tracks early visual quality after myopia surgery

A recent study published in Eye Discovery evaluated the early visual quality after KLEx surgery using the VISUMAX 800 platform. The study found excellent safety and efficacy outcomes, with most subjective visual symptoms improving over time. However, glare symptoms persisted longer than expected, highlighting the need for preoperative ...

SourceEye Discovery·JournalEye Discovery·TypeObservational study·DateJun 23, 2026

Patients who had cataracts removed or their eyesight corrected with a new type of lens have good vision over all distances without spectacles

Patients who had cataract surgery or received a new type of lens for presbyopia correction have excellent vision over near, intermediate, and far distances without glasses. The study found that nearly all patients needed glasses 'none' or 'a little of the time' for distance and intermediate vision.

Digital screen time and nearsightedness

A systematic review and dose-response meta-analysis found a daily 1-hour increment in digital screen time was associated with a 21% higher odds of myopia. Researchers suggest that exposure to screens for less than 1 hour per day may be safe, but prolonged use increases the risk of nearsightedness.

SourceJAMA Network·JournalJAMA Network Open·DateFeb 21, 2025

ASU researchers use AI to help people see more clearly

Researchers at Arizona State University have developed new diagnostic tools using artificial intelligence (AI) to help identify myopic maculopathy, a serious eye condition. The AI-powered systems can analyze retinal images and predict the correct classification of the disease, enabling more accurate treatment recommendations.

SourceArizona State University·JournalJAMA Ophthalmology·TypeNews article·DateOct 2, 2024

Global prevalence of short-sightedness in children and teens set to top 740 million cases by 2050

The global prevalence of myopia is projected to exceed 740 million cases by 2050, with females, East Asians, and those in urban areas showing higher rates. The condition's impact on children and teens is expected to be significant, with low and middle-income countries predicted to have a higher prevalence than high-income countries.

SourceBMJ Group·JournalBritish Journal of Ophthalmology·TypeSystematic review·DateSep 24, 2024

Imaging fibrous structure abnormalities of the white of the eye in myopathic patients

A team of researchers from Tokyo Medical and Dental University developed a novel kind of optical coherence tomography (OCT) to investigate the detailed structure of the sclera in living patients. They found that the sclera is divided into inner and outer layers with different structural arrangements, which can provide important insight...

SourceTokyo Medical and Dental University·JournalJAMA Ophthalmology·DateMay 16, 2024

A study from China reported a high prevalence of high myopia and pathological myopia but a lack of awareness in this patient population. Increased patient education about the disease needs to be emphasized

A study from China found a high prevalence of high and pathological myopia, yet inadequate patient education. The research highlights the need to improve awareness about these eye diseases to reduce adverse outcomes.

SourceSichuan International Medical Exchange and Promotion Association·JournalMedComm – Future Medicine·TypeSurvey·DateDec 13, 2023

Low-dose atropine eyedrops no better than placebo for slowing myopia progression

A randomized controlled trial funded by NIH found low-dose atropine eyedrops to be no better than placebo in slowing myopia progression among US children. The study contradicts previous East Asian trials that showed a benefit from 0.01% atropine. Further research is needed to identify an optimal approach for preventing high myopia.

SourceNIH/National Eye Institute·JournalJAMA Ophthalmology·TypeRandomized controlled/clinical trial·DateJul 13, 2023

Eye drops slow nearsightedness progression in kids, study finds

A new clinical trial found that low-dose atropine eye drops are effective in slowing the progression of nearsightedness in children. The treatment showed significant improvements in limiting eyeglass prescription changes and inhibiting elongation of the eye, with a daily drop in each eye being enough to make a difference.

SourceOhio State University·JournalJAMA Ophthalmology·TypeRandomized controlled/clinical trial·DateJun 1, 2023

New lens analysis approach could improve treatments for nearsightedness

Researchers have developed a new instrument to thoroughly characterize the optical properties of specialized eyeglass lenses used to slow myopia progression. The study's findings provide valuable information on how these lenses interact with eye elongation and shed light on their effectiveness in real-world scenarios.

SourceOptica·JournalOptica·TypeExperimental study·DateMay 11, 2023

Peer review affirms MiSight® 1 day sustains slowing of eye growth over six years for myopia control

A new peer-reviewed study confirms MiSight 1 day contact lenses slow eye growth and halt myopia progression in 90% of children, with no loss of effectiveness over time. The longest-running soft contact lens study among children demonstrates sustained efficacy for nearly all children, regardless of age or initial refractive error.

SourceMcDougall Communications·JournalOptometry and Vision Science·TypeRandomized controlled/clinical trial·DateMar 10, 2022

Rise in childhood short-sightedness may be linked to pandemic, suggests Hong Kong study

A Hong Kong study suggests a link between the COVID-19 pandemic and an increase in childhood short-sightedness, with children spending less time outdoors and more time on screens. The study found that around 1 in 5 children developed short-sightedness during the pandemic, compared to around 1 in 3 over three years.

SourceBMJ Group·JournalBritish Journal of Ophthalmology·TypeObservational study·DateAug 2, 2021